Innovating Works
CHILD-INNOVAC: NASAL VACCINATION AGAINST RESPIRATORY INFECTIONS IN YOUNG CHILDREN FUJIREBIO EUROPE NV participó en un FP7: Respiratory infections are the most frequent cause of childhood morbidity and mortality worldwide. For many respiratory pathogens no vaccine...
Financiado
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.